Global bioinformatics services market is anticipated to reach USD 4.1 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of I.T. solutions for different studies such as cell signaling, pathway metabolism, gene-receptor interactions, and target differentiation are expected to support growth in this market over the forecast period.
Owing to the benefits associated with the use of informatic solutions for laboratory protocol generation and data management as well as analysis, these solutions are projected to witness substantial demand in the coming years.
Moreover, collaborative activities undertaken by the information technology companies with pharmaceutical companies and clinical research organizations in order to develop and update key technologies linked to cloud computing, like online data storage and visualization of computer resources are expected to enhance market potential through to 2024.
View
summary of this report @ http://www.grandviewresearch.com/industry-analysis/bioinformatics-services-market
Further key findings from the report suggest:
·
NGS is estimated to be the dominant segment with
respect to the type of service served in 2015 owing to the fact that
sequence-based approach of analysis can be cataloged with the structure-based
approach as complementary to genomic and proteomic approaches. Advancement in
the sequencing technologies such as NGS and scripting tools (Perl & Python)
for sequence manipulation coupled with the reduction in prices of the
sequencing platforms and market movement towards the USD 1,000 genome resulted
in a larger revenue share of this segment in the discovery informatics.
·
Market revenue from of chemoinformatics is
second only to NGS and its strong market position can be accounted for by
presence of several entities operating in this segment and their involvement in
the provision of lead identification, validation, assay development, lead
generation, optimization, and clinical trial based informatic solutions.
·
Depending on the application, transcriptomics is
anticipated to register the fastest growth of over 15% owing to rise in the
number of projects carried out in translational research and application of RNA
transcripts for studying etiology of chronic as well as acute diseases.
·
Academic sector, in terms of end-use for these
services, is expected to witness the fastest growth through to 2024 as a result
of rise in the adoption rate of these technologies in genomic, proteomic and
metabolomics research programs carried out by universities research institutes.
If not all, most of these programs are either backed through government funding
or private corporation backing and forms a considerable part of the high
R&D investment that the bioinformatics market attracts in the current
scenario.
·
North America dominated the industry in 2015,
accounting for a little 35% of total revenue. Presence of key participants
operating in the region which are involved in development of novel algorithms
and software in order to improve drug attrition rates which consequently
increases adoption rate of computational algorithms is attributive for the
largest share of North America in sector revenue. Demand for informatic
services in Europe is also increasing owing to the presence of universities in
Germany and UK that are involved in development of I.T. solutions for
pharmaceutical research.
·
Asia Pacific is estimated to witness the fastest
growth over the forecast period owing to the fact that government and
regulatory authorities have implemented a framework to encourage R&D
collaborations and framework extension. Active expansion strategies undertaken
by a number of the major market entities operating in the American market in
order to strengthen their position in Asia Pacific region is a factor
anticipated to consequently drive growth.
·
Key players operating in this industry include
Agilent technologies, Siegen Inc., GVK Biosciences, Accelerys Inc, Illumina
Inc., DNAnexus, Life Technologies Corporation, Geneva Bioinformatic, Celera
Corporation, IBM Life sciences, and Affymetrix.
·
These entities are adopting strategies such as
collaborations with pharmaceutical and biotechnology companies in order to
enhance industrial presence by providing different data management and
analytical services for the purpose of drug design and therapeutic monitoring.
Read detailed report or request for sample of this research report: - http://www.grandviewresearch.com/industry-analysis/bioinformatics-services-market/request
Grand View Research has segmented bioinformatics services market on the basis of service type, sector, application, and region:
Global Bioinformatics Services Outlook, by Type (Revenue, USD Million, 2013 - 2024)
·
NGS
·
Targeted Sequencing Analysis
·
Transcriptome Analysis
·
Whole Genome
·
Chip Seq Analysis
·
De novo Assembly
·
Methyl Seq Analysis
·
Cheminformatics
·
Sequence Analysis Platforms
·
Molecular Modeling
·
Docking
·
Clinical trial data management
·
Others
·
Microarray data analysis
·
Biological data curation
·
Scientific software testing
·
Other services
Global Bioinformatics Services Outlook, by Application (Revenue, USD
Million, 2013 - 2024)
·
Genomics
·
Transcriptomics
·
Proteomics
·
Metabolomics
·
Drug Discovery
·
Others
Global Bioinformatics Services Outlook, by Sector (Revenue, USD
Million, 2013 - 2024)
·
Medical
·
Animal
·
Agricultural
·
Academics
Bioinformatics Services Regional Outlook (Revenue, USD Million, 2013
- 2024)
·
North America
·
U.S.
·
Canada
·
Europe
·
Germany
·
UK
·
Asia Pacific
·
China
·
Japan
·
Latin America
·
Brazil
·
MEA
·
South Africa
Browse
more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology
No comments:
Post a Comment